Follow-The-Filings

Security · featured owners

EWTX Edgewise Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 1.8%
  • $30M
  • 1 add

Who owns this now

Largest portfolio weights among featured holders · max 1.8% (James Silverman - Opaleye...) · not free-float ownership

  1. James Silverman 1.8%
  2. Nathan Fischel add 1.8%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 1.8% Hold 500,000 $20M history
Nathan Fischel - Dafna Capital Management 2026 Q2 1.8% Add +102.1% 226,819 $9M history

2 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$100.16M -$133.81M -$167.8M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $327M $475.48M $543.38M
Total non-current assets * $13.04M $11.33M $9.22M
Total assets $340.04M $486.82M $552.6M
Total current liabilities $16.77M $23.86M $27.37M
Total non-current liabilities * $4.43M $3.74M $2.98M
Total equity $318.83M $459.22M $522.26M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$91.95M -$109.03M -$143.82M
Cash from investing $102.89M -$184.66M -$32.79M
Cash from financing $53.17M $249.25M $196.09M
Net change in cash $64.1M -$44.43M $19.48M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders